Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Female patients who deliver twins vs singletons are more apt to return to the hospital for CVD, especially during the first ...